托克索普拉斯马淋亚斯巴达蛋白酶5:基质结合和抑制机制的结构基础
Satadru Chakraborty1, Anuradha Deshmukh1, Pooja Kesari1
1Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, India.
Journal of biomolecular structure & dynamics
|March 1, 2024
概括
这项研究揭示了Toxoplasma gondii asparticprotease 5 (TgASP5) 的结构细节,TgASP5是寄生虫感染中的关键酶. 了解它的活性部位和抑制剂结合对于开发新的抗毒素菌疗法至关重要.
科学领域:
- 寄生虫学的寄生虫学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 毒素菌在人类和动物中引起毒素菌.
- 通过成熟的效应蛋白,TgASP5对于寄生虫的毒性至关重要.
- 抑制TgASP5是一种潜在的治疗策略.
研究的目的:
- 为了对TgASP5成熟酶进行详细的结构研究.
- 了解活动站点架构和基板识别.
- 为了确定治疗开发的强效抑制剂.
主要方法:
- 分子建模和全原子模拟.
- 基板 (TEXEL) 结合模式的分析.
- 使用对接,MD模拟和MM-PBSA,对已知阿斯巴巴特蛋白酶抑制剂进行查.
主要成果:
- 阐明了TgASP5的详细活动站点架构.
- 确定了基质特异性的关键残留物 (Ser505,Ala776,Tyr689).
- 通过RRL_Statine进行抑制的分子基础详细说明.
- 新型抑制剂 (SC6,ZY1,QBH) 的结合能量比RRL_Statine的结合能量更高.
结论:
- 结构洞察力有助于开发强效的TgASP5抑制剂.
- 这些发现有助于设计针对复杂寄生虫的抗寄生剂.
- 这项研究为新的毒素菌治疗提供了基础.
关键词:
这是一种RRLStatine抑制剂.德克塞尔基板的基板在TgASP5中使用.毒素体 (Toxoplasma) 是一种毒素体.复合体是一种寄生虫.亚斯帕尔特蛋白质酶是一种亚斯帕尔特蛋白质酶.分子动力学分子动力学更多相关视频
相关概念视频
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Enzymes
81.5K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
81.5K
Enzyme Inhibition
78.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.3K
ATP Synthase: Mechanism
14.6K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.6K
Introduction to Mechanisms of Enzyme Catalysis
8.1K
For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes...
8.1K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K


